Travere Therapeutics (TVTX) Gross Profit (2014 - 2026)
Travere Therapeutics (TVTX) reported Gross Profit of $167.41 million for Q2 2026, up 48.2% from $112.93 million a year earlier and up 33.7% from the prior quarter.
Powered by 
Analysis
Travere Therapeutics (TVTX) Gross Profit (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Travere Therapeutics' Gross Profit came in at $583.07 million, up 80.2% year-over-year; for FY2025, it came in at $480.39 million, up 113.1% from FY2024.
- Gross Profit has increased for three consecutive years, with a five-year compound annual growth rate of 20.1% (FY2020 to FY2025).
- By year, Gross Profit came in at $225.43 million in FY2024 (+68.5%), $133.79 million in FY2023 (+27.4%), $105.04 million in FY2022 and $8.18 million in FY2021 (-95.7%).
- The Q2 2026 figure ranks as the highest quarterly Gross Profit in data going back to Q1 2014.
- Year over year, Gross Profit has now increased in each of the last 15 quarters, with growth averaging 89.1% over the last eight quarters.
- The high point for year-over-year Gross Profit in five years was Q3 2025 (growth of 166.5%); the low point was Q4 2021 (a decline of 73.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $125.25 million (Q1 2026), $127.14 million (Q4 2025) and $163.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Travere Therapeutics | 5.55 Bn | 5.14 Bn | 167.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 167.41 Mn |
| Mar 31, 2026 | 125.25 Mn |
| Dec 31, 2025 | 127.14 Mn |
| Sep 30, 2025 | 163.27 Mn |
| Jun 30, 2025 | 112.93 Mn |
| Mar 31, 2025 | 77.05 Mn |
| Dec 31, 2024 | 72.23 Mn |
| Sep 30, 2024 | 61.27 Mn |
| Jun 30, 2024 | 52.06 Mn |
| Mar 31, 2024 | 39.87 Mn |
| Dec 31, 2023 | 40.50 Mn |
| Sep 30, 2023 | 35.81 Mn |
| Jun 30, 2023 | 30.74 Mn |
| Mar 31, 2023 | 26.74 Mn |
| Dec 31, 2022 | 28.47 Mn |
| Sep 30, 2022 | 26.96 Mn |
| Jun 30, 2022 | 26.58 Mn |
| Mar 31, 2022 | 21.27 Mn |
| Dec 31, 2021 | 13.07 Mn |
| Sep 30, 2021 | 66.63 Mn |
API Access
Travere Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=TVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "TVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=TVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();